doi: 10.3390/molecules25030609 5
May be it can help with insulin, make you less tired and help control your weight
Apart from its unclear safety profile in clinical research, we can conclude, based on our dealings with prescribers, that KPV administered subcutaneously can cause certain side effects that are common to most therapeutic peptide injectables: injection site reactions and mild, transient flu-like symptoms
Further investigations by Moody and Holst indicated that the peptide either was or constituted part of a proglucagon precursor because similar fragments could be found in the pancreas (Moody, Holst, Thim, Lindkaer, Jensen)
Their flexibility makes peptides attractive drug candidates
Retatrutide in research settings typically arrives as lyophilized powder requiring reconstitution with bacteriostatic water